Ken Griffin’s Oasmia Pharmaceutical AB OASM Stock Holding History

Ken Griffin’s Portfolio OASM Stock Details OASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-16,734	Closed	-$22K	–	9542
2018 Q1	$22K	Sell	16,734 -1,754	-9%	-$2.3K	﹤0.01%	8109
2017 Q4	$16K	Buy	+18,488	New	+$17.8K	﹤0.01%	7867
2016 Q3	–	Sell	-11,462	Closed	-$39K	–	8057
2016 Q2	$39K	Buy	+11,462	New	+$48.1K	﹤0.01%	6460

Other funds holding OASM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ken Griffin's OASM Position: Q2 2018 in Review

Ken Griffin sold out of Oasmia Pharmaceutical AB (OASM) in Q2 2018, closing a stake of 16,734 shares — an estimated $22K sold.

Ken Griffin first reported a position in OASM in Q2 2016 and held it in 3 quarters. The position peaked at $39K in Q2 2016. 5 funds tracked by Wall St. Rank hold OASM as of Q2 2018.

Ken Griffin reported no remaining Oasmia Pharmaceutical AB position as of Q2 2018 after selling out during the quarter.
Ken Griffin sold 16,734 Oasmia Pharmaceutical AB shares in Q2 2018, an estimated $22K.
Ken Griffin first reported a position in Oasmia Pharmaceutical AB in Q2 2016 and held it in 3 quarters.
Ken Griffin's Oasmia Pharmaceutical AB position peaked at $39K in Q2 2016.
5 funds tracked by Wall St. Rank held Oasmia Pharmaceutical AB as of Q2 2018.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.